The evasive promise of antiangiogenic therapy

Affiliations

Comment

Jean-François Dufour. J Hepatol. 2009 Nov.

. 2009 Nov;51(5):970-2.

doi: 10.1016/j.jhep.2009.07.006. Epub 2009 Jul 21.

¹ Institute of Clinical Pharmacology and Visceral Research, University of Berne, Berne, Switzerland. jf.dufour@ikp.unibe.ch

No abstract available

Comment on

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis.
Pàez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Viñals F, Inoue M, Bergers G, Hanahan D, Casanovas O. Pàez-Ribes M, et al. Cancer Cell. 2009 Mar 3;15(3):220-31. doi: 10.1016/j.ccr.2009.01.027. Cancer Cell. 2009. PMID: 19249680 Free PMC article.
Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis.
Ebos JM, Lee CR, Cruz-Munoz W, Bjarnason GA, Christensen JG, Kerbel RS. Ebos JM, et al. Cancer Cell. 2009 Mar 3;15(3):232-9. doi: 10.1016/j.ccr.2009.01.021. Cancer Cell. 2009. PMID: 19249681 Free PMC article.